Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Kalkine 0
countryflagAU

PharmX Technologies Limited

Healthcare AU PHX

0.091AUD
-0.002(2.15%)

Last update at 2025-06-20T05:45:00Z

Day Range

0.090.09
LowHigh

52 Week Range

0.030.10
LowHigh

Fundamentals

  • Previous Close 0.09
  • Market Cap54.46M
  • Volume657786
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA0.50M
  • Revenue TTM8.63M
  • Revenue Per Share TTM0.01
  • Gross Profit TTM 3.96M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -0.71900M 0.30M 1.36M 0.46M -3.98300M
Minority interest - - - - -
Net income -1.05100M 0.25M 1.09M 0.18M -4.20500M
Selling general administrative 2.84M 8.22M 7.17M 7.32M 7.50M
Selling and marketing expenses 0.17M 0.26M 0.16M 0.47M 0.62M
Gross profit 4.81M 10.52M 10.77M 7.91M 8.99M
Reconciled depreciation 0.99M 2.17M 1.83M 0.80M 0.41M
Ebit -0.66500M 0.37M 1.50M 1.98M 4.01M
Ebitda 0.33M 2.54M 3.32M 2.78M 4.42M
Depreciation and amortization 0.99M 2.17M 1.83M 0.80M 0.41M
Non operating income net other - - - - -
Operating income -0.66500M 0.37M 1.50M 1.98M 4.01M
Other operating expenses 7.08M 13.74M 13.61M 10.45M 10.67M
Interest expense 0.05M 0.07M 0.14M 0.05M 7.99M
Tax provision 0.16M 0.28M 0.27M 0.28M 0.22M
Interest income 0.05M 0.03M 0.11M 1.73M 0.13M
Net interest income 0.06M -0.04200M -0.02800M 0.04M 0.13M
Extraordinary items -0.16800M 0.23M 0.01M - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.16M 0.28M 0.27M 0.28M 0.22M
Total revenue 6.02M 11.92M 12.70M 9.12M 10.13M
Total operating expenses 5.87M 12.34M 11.68M 9.25M 9.53M
Cost of revenue 1.21M 1.40M 1.94M 1.20M 1.14M
Total other income expense net 0.29M -0.07100M -0.13600M -1.51700M -7.99200M
Discontinued operations -0.16800M 0.23M 0.23M 0.23M 0.23M
Net income from continuing ops -0.88300M 0.02M 1.09M 0.18M -4.20500M
Net income applicable to common shares -1.05100M 0.25M 1.09M 0.18M -4.20500M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 29.86M 36.52M 30.77M 31.35M 19.18M
Intangible assets 10.81M 11.24M 18.61M 17.17M 4.67M
Earning assets - - - - -
Other current assets 0.08M 7.18M 1.70M 1.19M 1.82M
Total liab 13.88M 14.31M 7.57M 8.42M 5.98M
Total stockholder equity 15.97M 22.21M 23.20M 22.93M 13.20M
Deferred long term liab - - - - -
Other current liab - 10.67M 3.89M 5.57M 4.47M
Common stock - 98.41M 98.37M 98.37M 89.72M
Capital stock 93.97M 98.41M 98.37M 98.37M 89.72M
Retained earnings -78.02200M -76.25300M -75.20200M -75.45400M -76.54500M
Other liab - 2.02M 2.43M 1.99M 0.19M
Good will 2.12M 2.12M 2.12M 2.12M -
Other assets - 0.53M 0.85M 0.85M 0.75M
Cash 13.14M 12.81M 5.76M 6.48M 2.32M
Cash and equivalents - - - 6.48M 2.32M
Total current liabilities 11.95M 12.29M 5.11M 6.39M 5.48M
Current deferred revenue - 0.92M 0.08M 0.10M 0.23M
Net debt - -12.77400M -5.43300M -6.15700M -1.59000M
Short term debt - 0.03M 0.30M 0.28M 0.42M
Short long term debt - - - - -
Short long term debt total - 0.03M 0.33M 0.32M 0.73M
Other stockholder equity - 0.06M 0.04M 0.02M 0.02M
Property plant equipment - 0.05M 0.60M 0.79M 1.23M
Total current assets 16.37M 22.59M 8.59M 10.42M 9.84M
Long term investments - - 0.15M 0.05M 2.88M
Net tangible assets - 8.85M 2.48M 3.65M 8.52M
Short term investments - 12.54M 5.25M - -
Net receivables 1.00M 0.95M 1.08M 0.86M 3.83M
Long term debt - - - - -
Inventory - 0.00000M 0.04M 0.03M 0.06M
Accounts payable 0.57M 0.67M 0.84M 0.43M 0.36M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 0.06M 0.04M 0.02M 0.02M
Additional paid in capital - - - - -
Common stock total equity - - - - 89.72M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.09M - - - -
Deferred long term asset charges - - - - -
Non current assets total 13.49M 13.93M 22.18M 20.93M 9.34M
Capital lease obligations 0.24M 0.03M 0.33M 0.32M 0.73M
Long term debt total - 0.00000M 0.02M 0.04M 0.31M
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Investments 1.75M -3.57200M -3.63900M -6.18600M -3.33600M
Change to liabilities - 7.63M -1.23700M -5.09400M -0.33200M
Total cashflows from investing activities - -3.57200M -3.63900M -6.18600M -3.33600M
Net borrowings - -0.31300M -0.31800M -0.43400M -0.35100M
Total cash from financing activities -4.62200M -0.32500M -0.36100M 7.18M 2.96M
Change to operating activities - -0.06700M 1.08M 0.33M 0.26M
Net income -1.76900M -1.05100M 0.02M 1.09M 0.18M
Change in cash 0.33M 7.05M -0.71900M 4.16M -0.01000M
Begin period cash flow 12.81M 5.76M 6.48M 2.32M 2.33M
End period cash flow 13.14M 12.81M 5.76M 6.48M 2.32M
Total cash from operating activities - 10.94M 2.19M 3.16M 0.37M
Issuance of capital stock - - - 8.94M 3.66M
Depreciation - 0.75M 2.17M 1.83M 0.80M
Other cashflows from investing activities - -0.21300M 0.34M -2.09700M -0.05200M
Dividends paid - - 0.00000M 0.90M 0.90M
Change to inventory - 0.03M -0.00800M 0.03M 0.01M
Change to account receivables - -0.06900M -0.22100M 3.66M -1.52100M
Sale purchase of stock -4.48900M - 0.00000M -0.39200M -0.30200M
Other cashflows from financing activities - -0.32500M -0.36100M -0.46900M -0.40100M
Change to netincome - 2.17M 1.22M 1.17M 1.17M
Capital expenditures 1.58M 3.36M 3.98M 4.09M 3.28M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital - 10.13M 1.97M 2.08M 2.12M
Stock based compensation - - - - -
Other non cash items - - -2.19300M -2.91700M -0.97700M
Free cash flow 1.62M -3.35900M -1.78200M -4.08900M -3.28400M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
PHX
PharmX Technologies Limited		 -0.002 2.15% 0.09 - - 6.31 3.45 7.34 34.80
PME
Pro Medicus Ltd		 2.73 1.00% 276.81 297.33 161.29 156.50 128.82 154.20 202.60
CGS
CogState Ltd		 0.03 1.82% 1.40 19.86 20.66 4.97 3.38 2.42 8.91
ONE
Oneview Healthcare PLC		 - -% 0.27 - - 21.96 9.25 11.11 -3.5247
ALC
Alcidion Group Ltd		 -0.001 1.09% 0.09 - 3.02 3.47 1.45 3.29 53.70

Reports Covered

Stock Research & News

View All

Profile

PharmX Technologies Limited, together with its subsidiaries, operates as a technology and software development company in Australia. It also operates PharmX, an electronic ordering gateway; PharmX Marketplace, an online sales and marketing platform; and PharmX Analytics which provides insights for operations of supplier and pharmacy customers. The company was formerly known as Corum Group Limited and changed its name to PharmX Technologies Limited in October 2023. PharmX Technologies Limited was incorporated in 1950 and is headquartered in Sydney, Australia.

PharmX Technologies Limited

17 Castlereagh Street, Sydney, NSW, Australia, 2000

Key Executives

Name Title Year Born
Mr. Nick England Interim CEO & Exec. Chairman NA
Ms. Zoe Hillier Chief Financial Officer NA
Mr. James Nevile Chief Operating Officer NA
Ms. Eryl Baron Company Sec. NA
Mr. Tom Culver Chief Executive Officer NA
Ms. Eryl Baron Company Secretary NA
Mr. Tom Culver Chief Executive Officer NA
Ms. Eryl Baron Company Secretary NA
Mr. Tom Culver Chief Executive Officer NA
Ms. Eryl Baron Company Secretary NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.